These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 1977728

  • 41. A benzophenazine derivative, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxy-benzo[a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors.
    Tsuruo T, Naito M, Takamori R, Tsukahara S, Yamabe-Mitsuhashi J, Yamazaki A, Oh-hara T, Sudo Y, Nakaike S, Yamagishi T.
    Cancer Chemother Pharmacol; 1990; 26(2):83-7. PubMed ID: 2161296
    [Abstract] [Full Text] [Related]

  • 42. Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
    Naito S, Koike K, Ono M, Machida T, Tasaka S, Kiue A, Koga H, Kumazawa J.
    Oncol Res; 1998; 10(3):123-32. PubMed ID: 9700723
    [Abstract] [Full Text] [Related]

  • 43. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T, Iida H, Yamashiro M, Tsukagoshi S, Sakurai Y.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3138-40. PubMed ID: 7150340
    [Abstract] [Full Text] [Related]

  • 44. Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides.
    Hagiwara M, Wakusawa S, Miyamoto K, Hidaka H.
    Cancer Lett; 1991 Nov 01; 60(2):103-7. PubMed ID: 1682033
    [Abstract] [Full Text] [Related]

  • 45. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S, Wakusawa S, Tajima K, Miyamoto K, Hagiwara M, Hidaka H.
    J Pharm Pharmacol; 1993 Apr 01; 45(4):268-73. PubMed ID: 8098366
    [Abstract] [Full Text] [Related]

  • 46. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M, Maruyama E.
    Cancer Res; 1988 Apr 15; 48(8):2064-7. PubMed ID: 3349478
    [Abstract] [Full Text] [Related]

  • 47. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M, Koike K, Rho MC, Kuwano M, Kishiye T, Komiyama K.
    Anticancer Drug Des; 2001 Apr 15; 16(4-5):255-60. PubMed ID: 12049484
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL.
    J Natl Cancer Inst; 1996 Jun 05; 88(11):747-53. PubMed ID: 8637029
    [Abstract] [Full Text] [Related]

  • 51. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L, Kitaichi K, Hui CS, Takagi K, Takagi K, Sakai M, Yokogawa K, Miyamoto KI, Hasegawa T.
    Clin Exp Pharmacol Physiol; 2000 Aug 05; 27(8):587-93. PubMed ID: 10901387
    [Abstract] [Full Text] [Related]

  • 52. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
    Wakusawa S, Nakamura S, Tajima K, Miyamoto K, Hagiwara M, Hidaka H.
    Mol Pharmacol; 1992 Jun 05; 41(6):1034-8. PubMed ID: 1614407
    [Abstract] [Full Text] [Related]

  • 53. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M, Ido M, Nagao Y, Kuwabara H, Hori H, Ohkubo T, Kawasaki H, Sakurai M.
    Leuk Res; 1991 Jun 05; 15(8):675-81. PubMed ID: 1895749
    [Abstract] [Full Text] [Related]

  • 54. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
    Takenaga K, Tagawa M, Sakiyama S.
    Anticancer Res; 1996 Jun 05; 16(2):681-5. PubMed ID: 8687114
    [Abstract] [Full Text] [Related]

  • 55. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.
    Hasegawa H, Sung JH, Matsumiya S, Uchiyama M, Inouye Y, Kasai R, Yamasaki K.
    Planta Med; 1995 Oct 05; 61(5):409-13. PubMed ID: 7480200
    [Abstract] [Full Text] [Related]

  • 56. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative.
    Pierré A, Dunn TA, Kraus-Berthier L, Léonce S, Saint-Dizier D, Régnier G, Dhainaut A, Berlion M, Bizzari JP, Atassi G.
    Invest New Drugs; 1992 Aug 05; 10(3):137-48. PubMed ID: 1428723
    [Abstract] [Full Text] [Related]

  • 57. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
    Chiang CD, Song EJ, Yang VC, Chao CC.
    Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
    [Abstract] [Full Text] [Related]

  • 58. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M, Ido M, Kuwabara H, Hori H, Ohkubo T, Kawasaki H, Sakurai M, Taniguchi K, Hamazaki M.
    Leuk Res; 1991 Aug 01; 15(4):255-62. PubMed ID: 2030607
    [Abstract] [Full Text] [Related]

  • 59. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM, Goldenberg S, Gottesman MM, Hait WN.
    Cancer Res; 1994 Feb 01; 54(3):730-7. PubMed ID: 7905786
    [Abstract] [Full Text] [Related]

  • 60. Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance.
    Tanabe H, Tasaka S, Ohmori H, Gomi N, Sasaki Y, Machida T, Iino M, Kiue A, Naito S, Kuwano M.
    Bioorg Med Chem; 1998 Nov 01; 6(11):2219-27. PubMed ID: 9881113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.